Moosavi Rahmaneh Sadat, Jahangir Sooltani Niloofar, Houshmand Massoud
Science and Research Branch of Islamic Azad University, Islamic Republic of Iran, Niloofar Jahangir Soltani.
Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Iran J Child Neurol. 2020 Spring;14(2):93-100.
Charcot-Marie-tooth disease type 4 (CMT4D) is an autosomal recessive form of Charcot-Marie-tooth disease with an earlier age of onset and greater severity, compared to other types of this disease. CMT4C and CMT4D are the most prevalent subtypes in Mediterranean countries due to the higher rate of consanguineous marriage. In this study, we aimed to identify p.R148X mutation in gene and p.R1109X mutation in gene (responsible for CMT4D and CMT4C, respectively) and to investigate other possible nucleotide changes in exon 14 of gene and exon 7 of gene in an Iranian population.
MATERIALS & METHODS: A total of 24 CMT4D patients, who were referred to Iran Special Medical Center, were clinically and electrophysiologically evaluated in this study. DNA was extracted from the patients' blood samples. Next, polymerase chain reaction (PCR) assay was carried out, and the products were sequenced and analyzed in FinchTV software.
None of the target mutations were found in this study. Sequencing of gene showed SNP rs1025476 (g.57975C>T) in 21 (87.5%) patients, including 7 homozygous and 14 heterozygous individuals.
Despite the high rate of mutations in some populations, it seems that they are very rare in Iranian CMT4D patients. Regarding the association of SNP rs1025476 with CMT4D, further assessments are needed to reach a better understanding of genetic markers and their genetic features and to propose better diagnostic and treatment plans for the Iranian population.
与其他类型的夏科-马里-图斯病(CMT)相比,4型夏科-马里-图斯病(CMT4D)是一种常染色体隐性形式的夏科-马里-图斯病,发病年龄更早且病情更严重。由于近亲结婚率较高,CMT4C和CMT4D是地中海国家最常见的亚型。在本研究中,我们旨在鉴定 基因中的p.R148X突变和 基因中的p.R1109X突变(分别导致CMT4D和CMT4C),并调查伊朗人群中 基因第14外显子和 基因第7外显子的其他可能的核苷酸变化。
本研究对总共24例转诊至伊朗特殊医疗中心的CMT4D患者进行了临床和电生理评估。从患者的血样中提取DNA。接下来,进行聚合酶链反应(PCR)分析,并在FinchTV软件中对产物进行测序和分析。
本研究未发现任何目标突变。 基因测序显示,21例(87.5%)患者存在SNP rs1025476(g.57975C>T),其中包括7例纯合子和14例杂合子个体。
尽管某些人群中的突变率很高,但在伊朗CMT4D患者中似乎非常罕见。鉴于SNP rs1025476与CMT4D的关联,需要进一步评估,以更好地了解遗传标记及其遗传特征,并为伊朗人群提出更好的诊断和治疗方案。